Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Urokinase is a direct plasminogen activator widely used in thrombotic diseases, especially in the Asian market. Due to the risk of bleeding, strict control of indications and dosages is required. Advances in recombinant technology have made its production safer and more efficient.